Valsartan Tablet
Product Images NDC 51655-695

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 51655-695). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 695 52 Master Bottle Label Approval Rev A 03 21)

Label for Valsartan Tablets USP 160 mg, containing 30 tablets. This prescription oral tablet is labeled with storage instructions, manufacturer details (Northwind Pharmaceuticals), and packaging information. The label includes the NDC 51655-695-52 and advises to see the package insert for dosage.*

FDA Label Image

Figure01 (Fig01)

A forest plot chart comparing valsartan versus captopril across various patient subgroups. The horizontal axis shows a scale ranging approximately from 0.5 to 1.5, indicating favorability toward valsartan or captopril. Subgroups include age, gender, ethnicity, geographic region, and beta-blocker use. Each subgroup has a point estimate and confidence interval displayed.*

FDA Label Image

Structuralformula (Structure)

Chemical structure of valsartan, showing its molecular arrangement with labeled functional groups and atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.